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APO-3, LARD) (Chinnaiyan et al., 1996; Kitson et al.,
1996; Marsters et al., 1996; Bodmer et al., 1997; Screaton
et al., 1997), DR4 (TRAIL-R1, APO-2) (Pan et al., 1997),
DR5 (TRAIL-R2, TRICK2, KILLER) (Pan et al., 1997; Sher-
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Michelle Ng,*k Hong-Bing Shu,² Andrew Wakeham,*
Christine Mirtsos,* Nobutaka Suzuki,*
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and Tak W. Mak*§
idan et al., 1997; Screaton et al., 1997; Walczak et al.,*Amgen Institute
1997; Wu et al., 1997), and DR6 (Pan et al., 1998). Fas-Department of Medical Biophysics
induced apoptosis has been one of the most intensivelyUniversity of Toronto and
studied signaling pathways in recent years. ActivationOntario Cancer Institute
of Fas by its ligand FasL results in the rapid recruitmentToronto, Ontario M5G 2C1
of FADD (Fas-associated death domain protein, alsoCanada
called Mort-1) (Boldin et al., 1995; Chinnaiyan et al.,²Department of Immunology
1995). FADD in turn recruits procaspase-8 (also calledNational Jewish Medical and Research Center and
FLICE [FADD-like IL-1b-converting enzyme] or MACH)University of Colorado Health Sciences Center
(Boldin et al., 1996; Muzio et al., 1996) via the homolo-Denver, Colorado 80206
gous ªdeath effector domainsº (DED) present in both³Tularik Inc.
proteins, forming the ªdeath-inducing signaling com-South San Francisco, California 94080
plexº (DISC) (Kischkel et al., 1995; Medema et al., 1997).
Binding of procaspase-8 to FADD is followed by the
autoproteolytic activation of caspase-8, thereby trig-Summary
gering a caspase cascade leading to cell death (Medema
et al., 1997; Martin et al., 1998; Muzio et al., 1998).Casper (c-FLIP) associates with FADD and caspase-8
Various lines of evidence, including gene targetingin signaling complexes downstream of death recep-
studies (Varfolomeev et al., 1998; Yeh et al., 1998; Zhangtors like Fas. We generated Casper-deficient mice and
et al., 1998), have been used to define the componentscells and noted a duality in the physiological functions
of the death signaling pathway. Studies of knockoutof this molecule. casper2/2 embryos do not survive
mice deficient for FADD or caspase-8 have confirmedpast day 10.5 of embryogenesis and exhibit impaired
the essential roles of these molecules in Fas-, TNF-R1-,heart development. This phenotype is reminiscent of
and DR3-associated apoptosis. In contrast, the physio-that reported for FADD2/2 and caspase-82/2 embryos.
logical mechanism that regulates Fas signaling has re-However, unlike FADD2/2 and caspase-82/2 cells,
mained elusive. A potential clue has emerged from thecasper2/2 embryonic fibroblasts are highly sensitive to
recent discovery of a new class of viral antiapoptoticFasL- or TNF-induced apoptosis and show rapid in-
proteins, the viral FLICE-inhibitory proteins (v-FLIPs)duction of caspase activities. NF-kB and JNK/SAPK
(Thome et al., 1997). v-FLIPs are composed of two DEDactivation is intact in TNF-stimulated casper2/2 cells.
domains that share structure and sequence homologyThese results suggest that Casper has two distinct
to the NH2-terminal half of procaspase-8. During Fasroles: to cooperate with FADD and caspase-8 during
signaling, v-FLIPs are recruited to the DISC and interfere
embryonic development and to mediate cytoprotec-
with the recruitment of procaspase-8, thereby inhibiting
tion against death factor±induced apoptosis.
Fas-induced apoptosis (Thome et al., 1997).
A cellular homolog of the v-FLIPs was recently identi-
Introduction fied by several different groups and was variously
named Casper, c-FLIP, I-FLICE, CASH, FLAME-1, MRIT,
Intricate regulatory mechanisms are required to control CLARP, or usurpin (Goltsev et al., 1997; Han et al., 1997;
critical biological processes such as apoptosis and or- Hu et al., 1997; Inohara et al., 1997; Irmler et al., 1997;
gan development. For example, the apoptotic signal in- Shu et al., 1997; Srinivasula et al., 1997; Rasper et al.,
duced by ligation of the Fas receptor (CD95, APO-1) 1998). The full-length Casper protein contains two DED
results in the deletion of unwanted cells such as self- domains and a caspase-like domain similar to that in
reactive lymphocytes (Nagata, 1997). However, Fas and caspase-8 but lacks key features of proteolytic en-
its downstream signaling machinery are present in most zymes. Several splice variants of Casper containing de-
cells (Tschopp et al., 1998), necessitating that the sui- fective caspase-like domains have also been described
cide signal be properly controlled to prevent undesired (Tschopp et al., 1998). The shortest variant of Casper,
cell death. also called c-FLIPS, closely resembles v-FLIP in that
Fas belongs to the death receptor (DR) family, a grow- the entire caspase-like domain is lacking. All Casper
ing subset of the tumor necrosis factor receptor (TNF-R) variants can bind to the DED domains of FADD and
family (Ashkenazi and Dixit, 1999; Wallach et al., 1999). caspase-8 and are implicated as inhibitors of apoptosis
Other known death receptors include TNF-R1 (Loet- through their interference with the recruitment of cas-
pase-8 to FADD. However, overexpression of most
Casper variants in wild-type (WT) cells in fact promotes§ To whom correspondence should be addressed (e-mail: tmak@
cell death (Goltsev et al., 1997; Han et al., 1997; Inoharaoci.utoronto.ca).
k These authors have contributed equally as second author. et al., 1997; Irmler et al., 1997; Shu et al., 1997). These
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Figure 1. Targeting of the Murine casper
Gene
(A) Design of the casper targeting construct.
The first three exons (filled boxes) and in-
tervening introns of the endogenous casper
locus are shown. The targeting construct was
designed to replace part of the first exon,
including the translation start site, and the
first intron with a PMC-neo cassette. M, Msc1
site.
(B) Southern blot analysis of genomic DNA
from two WT and two casper1/2 ES cell lines.
Blots of DNA digested with MscI were hybrid-
ized to the radiolabeled flanking probe indi-
cated in (A). WT, band representing the WT
casper allele; MT, mutated casper allele.
(C) PCR genotyping of a litter of embryos from
a casper1/2 intercross.
(D) E9.5 WT (left) and casper2/2 (right) em-
bryos. Pericardial edema and hemorrhage
can be seen in the mutant embryo. Abbrevia-
tions: H, heart; PC, pericardial cavity; LB, limb
bud; Ov, otic vesicle.
(E) Northern blot analysis of casper expres-
sion. Blots of 30 mg total RNA from WT or
casper2/2 EF were hybridized to a full-length
casper cDNA probe.
(F) Immunohistochemical staining of Casper
in a sagittal section of a WT E9.5 embryo. The
signal is most intense in the heart (arrow).
Abbreviations: A, atrium; V, ventricle; FB,
forebrain.
Bar: 700 mm in (D); 500 mm in (F).
contradictory observations serve to illustrate the com- (Varfolomeev et al., 1998; Yeh et al., 1998). However,
Casper-deficient embryonic fibroblasts (EF) were highlyplexity of apoptotic signal regulation.
In addition to its association with FADD and caspase-8, sensitive to apoptosis induced by FasL and TNF and
showed rapid induction of procaspase processing. ThisCasper is capable of interacting with TRAF1 and TRAF2,
components of TNF receptor signaling complexes (Shu result stands in contrast to previous data obtained from
study of FADD2/2 and caspase-82/2 EF cells, which wereet al., 1997). TRAF2 is important in mediating TNF-medi-
ated activation of c-Jun N-terminal kinase (JNK, also shown to be highly resistant to death receptor±induced
apoptosis. Our results show that Casper is an importantcalled stress-activated protein kinase [SAPK]) and, to a
lesser extent, the transcription factor NF-kB (Rothe et regulator for apoptotic signaling induced by Fas and
TNF-R1.al., 1994; Lee et al., 1997; Yeh et al., 1997). Since both
FADD and TRAF2 are known to function downstream of
TNF-R1 engagement (Hsu et al., 1996), this interaction Results
suggests that Casper can also play a part in TNF signal-
ing. Moreover, the highest level of Casper expression in Casper Is Required for Embryonic Survival and Is
Highly Expressed in the Developing Heartadult tissues is found in the heart. Since cells undergoing
apoptosis after a myocardial infarct have decreased The murine casper gene was disrupted in embryonic
stem (ES) cells using the targeting vector shown in Fig-Casper expression (Rasper et al., 1998), it has been
proposed that a key function of Casper is to protect ure 1A. The targeting vector was designed to delete part
of the first exon, including the start codon, and to replacecardiac myocytes. However, the physiological relevance
of these observations remains to be investigated. it with a PMC-neo cassette. Two independent heterozy-
gous ES cell lines containing the mutated casper alleleTo study the physiological role of Casper and to re-
solve the above-mentioned controversies, we have gen- were injected into C57BL/6 (B6) blastocysts, and
casper1/2 animals were generated from male chimeraserated Casper-deficient mice by gene targeting. We
demonstrate that Casper is required for embryonic sur- with germline transmission. Homologous recombination
and genotype screening were examined by polymerasevival and cardiac development. This phenotype is similar
to that exhibited by FADD2/2 and caspase-82/2 embryos chain reactions (PCR) and confirmed by Southern blot
Casper in Death Signaling and Embryo Development
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Figure 2. Heart Morphology and Markers in
Casper-Deficient Mice
(A and B) H&E staining of sagittal (sag) sec-
tions of hearts from E9.5 WT (A) and casper2/2
(B) embryos. casper2/2 embryos are develop-
mentally delayed compared to WT lit-
termates. The rapid expansion and compac-
tion of the myocardium and the increase in
volume of the atrium, ventricle, and associ-
ated structures observed in the WT embryo
does not occur in mutants. Note the reduced
trabeculation (arrows in [A] and [B]).
(C and D) Horizontal (hor) sections of E10.5
WT (C) and casper2/2 (D) embryos. Differ-
ences that were first observed at E9.5 are
more pronounced in mutants surviving to
E10.5.
(E±H) In situ hybridization experiments for de-
velopmental markers. c-actin (c-Act) expres-
sion was used as a probe for myocardium (E
and F), while TEK expression was used as a
marker for endocardium and vessel endothe-
lium (G and H). Similar intensities of expres-
sion were observed for both c-actin and TEK
in WT (E and G) and casper2/2 (F and H) em-
bryos. However, reduced trabeculation was
evident when WT (E) and mutant embryo (F)
sections were compared (arrowheads in [E]
and [F]).
(I and J) TUNEL staining of heart tissue from
E9.5 WT (I) and casper2/2 (J) embryos. Posi-
tive staining indicating apoptotic cells was
rarely observed in viable WT or mutant em-
bryos at this stage. Some sporadic positive
staining was seen in other parts of WT and
mutant embryos (arrowhead in [J], connec-
tive tissue outside of pericardium).
Bar: 200 mm in (A)±(D); 100 mm in (E), (F), (I),
and (J); 500 mm in (G) and (H). Abbreviations:
AS, aortic sac; SV, sinus venosus; V, common
ventricular chamber; AC, common atrial
chamber; P, pericardium; PC, pericardial cav-
ity; Tr, trabeculae.
analysis (Figures 1B and 1C). No abnormalities were expressed most highly in the developing heart (Figure
1F), a result consistent with the expression pattern ofobserved in casper1/2 mice. However, no homozygous
casper2/2 mutants were identified in the more than 100 Casper previously reported in adult tissues (Rasper et
al., 1998).live-born pups that were initially genotyped from
casper1/2 heterozygous intercrosses.
Analysis of timed breedings subsequently showed Casper Is Required for Embryonic
Heart Developmentthat viable casper2/2 embryos were present at the ex-
pected Mendelian frequency up to E9.5 (Figure 1C). Histological analyses of E9±E9.5 casper2/2 embryos re-
vealed that most developed normally up until this stage,However, by E10.5, all casper2/2 embryos (21% of the
total) appeared abnormal, and no viable mutant em- but some began to show signs of defective formation
of cardiac trabeculae as well as a thinner myocardiumbryos were present at E11.5. Gross examination of mu-
tant embryos at E9.5 or E10.5 revealed that they were (Figures 2A and 2B). Other organ systems of mutant
embryos appeared normal at this stage. The cardiacmildly underdeveloped with distension of the pericardial
cavity (Figure 1D). Blood pooling in the head and abdom- phenotype became apparent in almost every E10.5 mu-
tant embryo and was accentuated by severe dilation ofinal regions was also observed. Northern blot analysis
using the full-length casper cDNA as a probe showed the pericardial space (Figures 2C and 2D), indicating
insufficiency of cardiac function. Expression of cardiacthat casper mRNA expression was absent in casper2/2
EF (Figure 1E), indicating that the mutation was null. actin (Figures 2E and 2F) and TEK, an endothelial-spe-
cific protein receptor tyrosine kinase (Dumont et al.,Mice derived from both mutant ES cell lines exhibited
identical phenotypes, indicating that these abnormali- 1992) (Figures 2G and 2H), was normal in casper2/2
embryos, indicating that Casper is not required for theties arose from a specific deficiency of Casper. To exam-
ine the spatial distribution of Casper during develop- expression of these proteins. Blood vessels were also
properly formed in the absence of Casper as determinedment, immunohistochemical analysis of sections of WT
embryos was performed. At E9.5 and E10.5, Casper is by analysis of TEK expression in whole embryos (Figures
Immunity
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Figure 3. Increased Death Receptor±Induced
Apoptosis in Casper-Deficient Cells
(A and B) WT and casper2/2 EFs were either
left untreated or incubated with increasing
concentrations of either FasL-CD8 fusion
protein (A) or recombinant murine TNF (B) as
indicated. Viable cells were identified 18 hr
later by negative staining for 7-amino actino-
mycin D; the results are expressed as a per-
centage of untreated controls.
(C) WT, casper1/2, and casper2/2 cells were
either left untreated or treated with high or
low concentrations of etoposide (L: 0.1 mM;
H: 1 mM), sorbitol (L: 0.1 M; H: 0.4 M), stauro-
sporine (L: 30 nM; H: 100 nM), or anisomycin
(L: 3 mM; H: 10 mM). Viability was determined
as for (A) and (B).
2G and 2H). Analyses of various gene knockout mice Casper, FADD, and caspase-8 is involved in embryonic
heart development in an apoptosis-independent manner.have shown that some embryos which die around E10.5
suffer from a failure of placental attachment and support
(Copp, 1995). However, gross examination of casper2/2 Casper-Deficient Cells Are Specifically Sensitive
embryos revealed normal chorioallantoic fusion and to Death Receptor±Induced Apoptosis
placenta formation. Histological analyses also showed Despite our histological finding of normal apoptosis in
normal establishment of fetal and maternal vascular net- Casper-deficient hearts, the results of previous in vitro
works in casper2/2 placentas (data not shown). studies of Casper activity and its molecular associations
The timing of the lethality of casper2/2 embryos and prompted us to investigate the involvement of Casper in
the link to cardiac failure brought to mind our previous apoptosis. Specifically, we examined how Casper might
studies of FADD-deficient animals (Yeh et al., 1998). interact with FADD and caspase-8, the initiators of death
Interestingly, embryos deficient for caspase-8, which cascade signaling downstream of Fas and its related
can associate with both Casper and FADD, also exhibit death receptors. Expression vectors for Fas, TNF-R1,
a similar defect in heart development (Varfolomeev et DR3, DR4, and DR5 were transiently transfected into
al., 1998). Since Casper, FADD, and caspase-8 have all WT and casper2/2 EF lines. After 24 hr, the vast majority
been implicated in death receptor±induced apoptosis, of both transfected WT and transfected casper2/2 cells
we next used TUNEL (TdT-mediated dUTP nick end were killed in all cases (data not shown). In contrast,
labeling) staining to determine whether there was a de- when untransfected WT and Casper-deficient cells were
fect in apoptosis in the casper2/2 embryonic heart. How- simply treated with FasL, WT cells were able to maintain
ever, after examining many sections from at least six 100% viability after 18 hr of treatment but 40%±50% of
different mutants and six littermate controls, we con- the mutant cells underwent apoptosis (Figure 3A). These
cluded that the extent of apoptosis was comparable in data were reproducible among four different casper2/2
WT and casper2/2 embryonic hearts (Figures 2I and 2J). EF lines examined in at least three independent experi-
In addition, cellular proliferation (as measured by BrdU ments. Untransfected casper2/2 EF cells were also
incorporation) was not reduced in viable casper2/2 mu- highly sensitive to TNF treatment alone (Figure 3B).
tants (data not shown). These results are strikingly simi- These results are remarkable because healthy WT EF
lar to those obtained for FADD-deficient embryos. We cells are normally resistant to FasL or TNF unless the
treatment is combined with serum deprivation or antherefore suggest that a signaling complex containing
Casper in Death Signaling and Embryo Development
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Figure 4. Regulation of Procaspase Activa-
tion by Casper
(A) Increased processing of procaspase-8
and procaspase-3 during TNF-induced apo-
ptosis in the absence of Casper. Cell lysates
(100 mg) from casper2/2 (left) or WT (right)
cells treated with TNF (100 ng/ml) for the indi-
cated times were examined by Western blot
analysis for expression of procaspase-8, pro-
caspase-9, procaspase-3, and FADD using
specific antibodies.
(B) Early induction of caspase-3 activity in
casper2/2 EF cells. WT and casper2/2 cells
were stimulated for the indicated times with
either TNF (100 ng/ml) or TNF plus cyclohexi-
mide (50 mg/ml) (WT only). Caspase-3 activity
was measured in cell lysates by incubation
with a fluorogenic substrate (Ac-DEVD-AMC).
inhibitor of de novo protein synthesis such as cyclohexi- levels of processed caspases in TNF-treated casper2/2
cells than WT cells (Figure 4B). Procaspase processingmide (Yeh et al., 1998). Furthermore, cycloheximide can
enhance the apoptotic effect of TNF in Casper-deficient in the mutant cells peaked at about 2 hr poststimulation.
In contrast, only at about 6 hr after treatment with TNFcells (data not shown). Our data suggest that rather than
being required for the cell death cascade itself, Casper (100 ng/ml) plus cycloheximide (50 mg/ml) did caspase-3
activity peak in WT cells, while activity was insignificantmay play an important regulatory role in controlling Fas-
and TNF-mediated apoptosis. at 2 hr poststimulation. Therefore, the deficiency of Cas-
per results in a faster kinetics of TNF-induced apoptosisTo examine the range of the ªdeath-proneº pheno-
type, casper2/2, casper1/2, and WT EF cells were treated than the addition of cycloheximide. This suggests that
the nature of apoptotic defect created by the absencewith various apoptotic stimuli that do not involve the
death receptor pathways. Cell lines of all three geno- of Casper is different from the one effected by cyclohex-
imide.types were killed to a similar degree by the chemothera-
peutic drugs etoposide (Figure 3C) or adriamycin (data
not shown). Treatment with other stimuli resulting in The Cytoprotective Effect of Casper Is Independent
of NF-kB and Stress Kinase Activationosmotic stress (sorbitol), protein kinase inhibition (stau-
rosporine), or protein synthesis inhibition (anisomycin) Susceptibility to TNF-induced cell death has been pre-
viously reported in cells lacking functional NF-kB (Begalso induced apoptosis to a similar extent in Casper-
competent and Casper-deficient EF cells (Figure 3C). and Baltimore, 1996; Liu et al., 1996; Van Antwerp et al.,
1996; Wang et al., 1996), a transcription factor known toTaken together, these results suggest that Casper is an
integral part of the death receptor signaling machinery be both activated by TNF and important for cytoprotection.
Since Casper is associated with the proximal componentsand that it plays a regulatory role specific to death recep-
tor pathways that is initiated upon ligand stimulation. of TNF receptor signaling (including TRAF2) (Shu et al.,
1997), we investigated whether Casper plays a role in
mediating TNF-induced NF-kB activation. As shown inTNF Triggers Rapid Activation of Caspase-8
and Caspase-3 in Casper-Deficient Cells Figures 5A and 5B, NF-kB activation was not impaired
in TNF-treated casper2/2 cells as determined by gel mo-We next examined the effect of the casper null mutation
on the activity of known components in the death recep- bility shift assays (Figure 5A) and reporter assays (Fig-
ure 5B).tor signaling pathway. In the absence of Casper, procas-
pase-8 was activated very quickly in response to TNF Activation of JNK/SAPK, another important down-
stream event triggered by TNF and mediated by TRAF2,treatment, as evidenced by a steady reduction in the
amount of procaspase-8 present (Figure 4A). In contrast, was also examined in casper2/2 EF cells. The precise
role of JNK/SAPK in the regulation of apoptosis is stillprocaspase-8 was not processed in WT cells in re-
sponse to TNF treatment alone. Procaspase-3 was acti- controversial, but the JNK/SAPK signaling pathway has
been implicated in cytoprotection (Nishina et al., 1997).vated with kinetics similar to those of procaspase-8
processing in Casper-deficient cells. Interestingly, the However, WT- and Casper-deficient cells showed com-
parable levels of TNF-induced JNK/SAPK activity (Fig-processing of procaspase-9, another upstream cas-
pase, was not induced in casper2/2 cells (or WT cells) ure 5C). Taken together, these results suggest that Cas-
per is not required for the activation of NF-kB or JNK/treated with TNF (Figure 4A). These results are consis-
tent with previous reports delineating the roles of these SAPK and likely protects cells through a mechanism
independent of both these pathways.caspases in TNF signaling (Hakem et al., 1998; Varfolo-
meev et al., 1998; Woo et al., 1998) and suggest that Finally, we investigated whether Casper was a target
gene activated by NF-kB in response to TNF stimulation,Casper acts to prevent inappropriate activation of cas-
pase-8 and caspase-3. since NF-kB has been implicated in the activation of
survival genes such as c-IAPs (Wang et al., 1998), IEX-Biochemical measurements of terminal caspase (e.g.,
caspase-3, -7) activities using a fluorogenic substrate 1L (Wu et al., 1998), and A1/Bfl1 (Grumont et al., 1999;
Noble et al., 1999; Wang et al., 1999; Zong et al., 1999).also revealed the presence of more rapidly elevated
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Figure 5. Normal TNF-Induced NF-kB and
JNK/SAPK Activation in casper2/2 Cells
(A) Unaltered DNA binding activity of NF-kB in
TNF-stimulated casper2/2 EF cells. casper2/2
(left) and WT (right) cells were treated with
100 ng/ml TNF for 0, 10, 30, or 90 min, nuclear
extracts were harvested, and gel mobility
shift assays were performed.
(B) Normal transactivation of an NF-kB target
gene in TNF-stimulated casper2/2 cells. For
the reporter assay, casper2/2 and WT cells
were transfected with the NF-kB-dependent
pELAM-luc reporter plasmid. After stimula-
tion with 50 ng/ml TNF for 4 hr, cell lysates
were assayed for luciferase activity.
(C) Comparable activation of JNK/SAPK in
TNF-treated WT and casper2/2 cells. EF cells
were stimulated with 100 ng/ml TNF for 0,
10, 30, or 90 min. Total protein lysates were
assayed for JNK/SAPK activity using an
N-terminal c-Jun-GST fusion protein as a
substrate.
(D) Casper expression is independent of NF-
kB. Northern blot analysis of RNA from WT
and RelA2/2 cells treated with 100 ng/ml TNF
for the indicated times was performed using
a full-length casper cDNA probe.
However, consistent with the result shown in Figure 4B, are comparable to those in WT littermates, even in the
heart. Paradoxically, examination of FADD expressionCasper was readily expressed in unstimulated WT cells
and only mildly induced upon TNF stimulation (Figure in embryos reveals that its mRNA is widely expressed
in a variety of tissues. A similar paradox applies to cas-5D). Moreover, in RelA2/2 cells, in which almost all NF-
kB activity is abolished (Beg et al., 1995), expression of pase-8, since caspase-82/2 mice also exhibit embryonic
lethality with a phenotype very similar to that of FADD2/2Casper was not altered by TNF stimulation. This result
suggests that the cytoprotective effect of Casper is embryos (Varfolomeev et al., 1998). Expression of cas-
pase-8 is also widespread, with its highest levels de-completely independent of NF-kB signaling.
tected in the primitive ventricle of the heart, limb buds,
branchial arches, dorsal mesentery, and some areas ofDiscussion
the brain (Varfolomeev et al., 1998).
Based on analyses by TUNEL staining, the lethalitiesIn this study, we analyzed Casper-deficient animals and
cells and demonstrated that Casper has two distinct of FADD2/2 embryos are probably not due to an increase
or decrease of apoptosis (Yeh et al., 1998). Interestingly,physiological roles. First, Casper is required for the
proper development of embryos, playing a particularly apoptosis defect is not a contributing factor to the heart
phenotype in Casper-deficient embryos either (Figureimportant role in the developing heart. Second, Casper
is essential for regulating death receptor±mediated apo- 2J), even though the highest levels of Casper expression
occur in the heart. It remains possible that the embryonicptosis induced by Fas or TNF-R1 engagement. These
results provide definitive evidence that Casper mediates phenotypes of the FADD2/2, caspase-82/2, and casper2/2
mice are similar by coincidence, that is, that Casper,a protective effect against death receptor±induced apo-
ptosis. Intriguingly, our data show that Casper is yet FADD, and caspase-8 function in unrelated pathways.
However, we favor the intriguing hypothesis that theseanother death receptor signal transducer that, like FADD
and caspase-8, is assigned an important function in three molecules, which can physically interact with each
other in the cytosol, cooperate in the same signalingheart development.
Involvement of FADD in embryonic heart development axis to facilitate myocardial development in a cell death±
independent manner. Alternatively, there may be duringwas also discovered through the study of knockout mice
and was at the time very surprising (Yeh et al., 1998). heart development an intricate balance of elements in
which FADD and caspase-8 combine to deliver a signalFADD was initially identified as an adaptor protein that
mediates apoptotic signaling through Fas and TNF-R1, that is antagonized by Casper. Deficiency of any of these
three molecules results in an imbalance of signaling andmolecules that play important roles in immune sys-
tem regulation. However, FADD-deficient embryos die impaired organogenesis.
An alteration in sensitivity to death receptor±mediatedaround E10.5±E11.5 with mild growth retardation and
defective myocardial development. Like Casper-defi- apoptosis of a given knockout cell has become an excel-
lent criterion for assigning or confirming the physiologi-cient embryos, the impairment in FADD2/2 embryo car-
diac function is primarily due to a failure of thickening cal role of a protein in these signaling pathways. To
date, only a handful of knockout mutations, includingand compaction of the ventricular myocardium and de-
creased trabeculation (Yeh et al., 1998). The extent of RelA2/2, rip2/2, traf22/2, and casper2/2, result in in-
creased apoptosis of cells in response to TNF treatmentcellular apoptosis and proliferation in FADD2/2 embryos
Casper in Death Signaling and Embryo Development
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stimulation. We envision that Casper forms a complex
with FADD and/or caspase-8 in both the ªonº and ªoffº
switch situations but that the primary function of Casper
in the ªoffº switch case is to disrupt the initiation of the
caspase cascade triggered by FADD and caspase-8
(Figure 6B). As mentioned above, however, we can not
rule out the possibility that Casper, FADD, and cas-
pase-8 are also involved in an antagonistic relationship
during embryonic heart development. Further experi-
ments, including generation of casper2/2FADD2/2 or
casper2/2caspase-82/2 mice are required to address
this issue.
Elevated expression of Casper has recently been
linked to the escape of tumors from immune surveillance
(Djerbi et al., 1999; Medema et al., 1999) and the resis-
tance of early activated T cells and differentiating mac-
rophages to cell death (Irmler et al., 1997; Refaeli et al.,
1998; Perlman et al., 1999). These observations suggest
that death receptor signaling pathways are important
in these biological processes and that modulation ofFigure 6. Model for the Two Distinct Physiological Roles Played by
Casper expression and death receptor signaling couldCasper
be therapeutically beneficial for patients with cancers(A) Requirement for Casper in heart development. Stimulation of an
or immune system disorders. In Casper-deficient cells,unknown receptor triggers a developmental signal that requires the
positive cooperation of FADD, caspase-8, and Casper. the ªoffº switch for apoptotic signaling is lost, making
(B) Requirement for Casper in the regulation of apoptosis induced these cells a valuable tool for future investigations into
by death receptors. The apoptotic signal transmitted from the death the nature and potential manipulation of death receptor
receptor through FADD to caspase-8 is modulated in the presence signaling.
of Casper, preventing uncontrolled cell death.
Experimental Procedures
(Beg and Baltimore, 1996; Yeh et al., 1997; Kelliher et Generation of casper1/2 and casper2/2 Mice by Gene Targeting
The targeting vector shown in Figure 1A was linearized and electro-al., 1998). Such findings are particularly insightful, as
porated into E14 ES cells (129/Ola). ES clones were selected in 300they suggest that physiological cytoprotective path-
mg/ml G418 (Sigma) in Dulbecco's modified Eagle's medium (DMEM)ways exist that are activated in response to stimuli trig-
supplemented with 15% fetal bovine serum (FBS) and leukemia
gered by these death factors. inhibitory factor (LIF). Homologous recombinants were identified by
While Casper apparently exerts a direct inhibitory ef- PCR and further analyzed by Southern blot hybridization using the
flanking probe depicted in Figure 1A or a neo-specific probe. Chime-fect on the death machinery, it is likely that NF-kB or
ric mice were produced by microinjection of heterozygous ES cellsits upstream signal transducers RIP and TRAF2 mediate
into E3.5 C57BL/6J blastocysts that were subsequently transferredthe cytoprotective effect through the induction of other
to CD1 pseudopregnant foster mothers. Chimerae were generated
target genes. One such candidate is c-IAP (cellular inhib- from two independent casper1/2 ES cell lines. Male chimerae were
itor of apoptosis proteins) family of proteins (Rothe et backcrossed with C56BL/6J females, and germline transmission in
al., 1995; Wang et al., 1998), which are capable of binding F1 casper1/2 mice was verified by Southern blot analysis. PCR prim-
ers for genotyping were as follows: 59-CTC GTC TTC ATC AAG ACAto the processed forms of terminal caspases and inhib-
CTC TTC CAC C-39 (wild type); 59-GTT CGA ATT CGC CAA TGAiting their activities (Deveraux et al., 1997; Roy et al.,
CAA GAC GCT GG (mutant); 59-GAC CAG TCG GAA GGT GAG GAC1997). The effect of c-IAP proteins on the terminal cas-
CTG TGC-39 (common). The mutant phenotype was analyzed in 129/
pases would seem to be perfectly complementary to C57BL/6 and 129/CD1 backgrounds; no significant differences were
Casper's effects on the initiator caspases. However, observed.
other cytoprotective proteins exist, including two re-
Histological Analysiscently identified candidates, IEX-1L (Wu et al., 1998) and
Embryos were dissected at E8.5±E10.5, fixed in 4% paraformalde-A1/Bfl1 (Grumont et al., 1999; Noble et al., 1999; Wang
hyde, dehydrated, embedded in wax, and processed according to
et al., 1999; Zong et al., 1999). standard protocols. Sagittal and horizontal sections of 7 mm thick-
The two distinct phenotypes of the casper2/2 mice ness were cut and stained with hematoxylin and eosin (H&E) ac-
identified in this study suggest that Casper may serve cording to standard protocols. For immunohistochemistry, sections
were incubated with anti-Casper antibodies (Santa Cruz) diluted atas a molecular ªon/offº switch, depending on whether
1:100. Staining was developed using an ABC kit (Vector Labs) anda developmental or death receptor signal is received.
diaminobenzidine (DAB) following the manufacturer's instructions.With respect to an ªonº switch function in a model of
embryonic heart development, one possibility is that the In Situ Hybridization
adaptor protein FADD receives signals from unknown For radioactive in situ hybridization, E9.5±E10.5 embryos were iso-
lated and processed as for histological analysis. Hybridization was(non-death) receptor(s) on myocardial cells and trans-
performed using 33P-labeled RNA probes specific for cardiac actinduces them through caspase-8 and Casper (Figure 6A).
and tek as previously described (Yeh et al., 1998).This developmental signal is independent of apoptosis
and requires input from Casper. With respect to an ªoffº TUNEL Assay
switch function, Casper may downregulate death recep- TUNEL (TdT-mediated dUTP nick end labeling) staining was performed
using an in situ cell death detection kit (Boehringer Mannheim,tor signaling, particularly that triggered by FasL or TNF
Immunity
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#1684817). Briefly, paraffin-embedded sections were dewaxed and mM dithiothreitol, 1 mg poly [dI-dC], and 10% glycerol) for 20 min
at room temperature. After incubation, samples were fractionatedrehydrated in phosphate-buffered saline (PBS) according to stan-
dard protocols. Sections were incubated with proteinase K (20 mg/ml) on a 5% polyacrylamide gel and visualized by autoradiography.
for 15 min at 378C. The reaction mixture, including DNA polymerase,
terminal deoxynucleotidyl transferase (TdT), and fluorescein-labeled JNK/SAPK Kinase Assay
JNK/SAPK activity was determined using a SAPK/JNK assay kitdUTP, was applied to the sections in a humidified chamber followed
by incubation for 60 min at 378C. Sections were then washed in from New England Biolabs. WT or casper2/2 EF cells (5 3 106) were
either untreated or treated with 100 ng/ml TNF for 10, 30, or 90 min.PBS, mounted, and analyzed under a fluorescence microscope.
Cells were then lysed and 250 mg total protein from each sample was
utilized to perform the kinase assay according to the manufacturer'sEmbryonic Fibroblast Death Assay
instruction.WT and Casper-deficient primary EF lines were derived from em-
bryos at E8.5 and cultured in DMEM supplemented with 10% FBS.
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